TEVA CORPORATE WEBSITE CONTACTS LINKS TAPI ITALY TEVA PRODUCTS PRESS RELEASES TEVA'S COMMITMENT COMMUNICATE WITH TEVA Home Products Equivalent drugs EQUIVALENT DRUGS EQUIVALENT DRUGS Equivalent medicines by their nature have a very well established efficacy and safety profile, having been on the market for at least 10 years in Italy or in another country of the European Community. More equivalent drugs means more health for a greater number of citizens. Thus drugs acquire a social value. The spread of a correct cultural approach towards equivalents by doctors, pharmacists and citizens represents a strategic choice, able to free up economic resources to invest in innovation and to facilitate access to new therapies. TEVA LEADER OF EQUIVALENTS TEVA IS A WORLD LEADER IN THE MANUFACTURE AND MARKETING OF EQUIVALENT DRUGS. DEFINITION EQUIVALENT DRUGS ARE AN EQUIVALENT THERAPEUTIC ALTERNATIVE TO BRAND NAME DRUGS. BIOEQUIVALENCE A FUNDAMENTAL FACTOR FOR THE EQUIVALENCE OF A DRUG. LIFE CYCLE OF EQUIVALENTS HOW DO YOU BECOME EQUIVALENT. THERAPEUTIC AREAS TEVA IS ABLE TO ADEQUATELY RESPOND TO THE DEMAND FOR HEALTH IN THE MAIN THERAPEUTIC AREAS. RECOMMENDED LINKS TEVA Introduction Teva in Italy Model pursuant to Legislative Decree 231/2001 Culture and values Teva in the world Teva on the stock exchange Responsible transparency PRODUCTS Teva quality Equivalent drugs Biosimilar drugs Brand-innovative drugs Package leaflets PRESS RELEASES 2016 2015 2014 2013 2012 TEVA'S COMMITMENT Donations 2015 DISCLAIMER AND LEGAL NOTES PRIVACY AND COOKIE POLICY COMMUNICATE WITH TEVA TEVA ITALIA S.R.L. Sede legale: Piazzale Luigi Cadorna, n. 4 – 20123, Milano (MI) Sede amministrativa e uffici: viale del Mulino, 1 pal. U10 - centro direzionale Milanofiori Nord 20090 Assago (Mi) Società con unico Socio Capitale Sociale Euro 1.460.000 iv (interamente versato) Codice Fiscale e Partita IVA N. 11654150157 Registro Imprese di Milano N. 11654150157 This site uses its own cookies and also reserves the right to use third-party cookies to ensure the functionality of the site and to take into account navigation choices. For more details and to know how to deny consent to all or some cookies, you can consult the cookie policy. By accessing any other element of the site you are consenting to the use of cookies Cookie policy X